SCHEMBL3883128

SCHEMBL3883128

CC(Oc1ccc(CCC(=O)O)cc1-c1ccc2c(cnn2C)c1)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 1/20 0.47
PDE1C Q14123 2/20 0.43
AR P10275 2/20 0.43
PDE2A O00408 1/20 0.43
PDE5A O76074 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
PDE1A P54750 1/20 0.43
PDE1B Q01064 1/20 0.43
PDE4B Q07343 1/20 0.43
PDE4D Q08499 1/20 0.43
PDE7A Q13946 1/20 0.43
PDE10A Q9Y233 1/20 0.43
FFAR4 Q5NUL3 3/20 0.42
LPAR1 Q92633 1/20 0.42
TRPA1 O75762 1/20 0.40
TP53 P04637 5/20 0.40
MDM2 Q00987 5/20 0.40
CCNC P24863 1/20 0.39
CDK8 P49336 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3880966 0.89 FFAR1 (0.45) FFAR1FFAR4TP53MDM2GCGR
SCHEMBL6837182 0.87 TRPA1 (0.50) FFAR1ARFFAR4TRPA1S1PR1
SCHEMBL3883923 0.86 AR (0.44) FFAR1PDE1CARPDE2APDE5A
SCHEMBL3882141 0.84 S1PR1 (0.45) ARFFAR4TP53MDM2CCNC
SCHEMBL3686723 0.84 FFAR4 (0.53) FFAR1PDE1CARFFAR4TP53
SCHEMBL3888350 0.81 THRA (0.44) ARFFAR4TP53MDM2CCNC
SCHEMBL3882670 0.81 FFAR1 (0.47) FFAR1FFAR4TRPA1TP53MDM2
SCHEMBL3881173 0.80 RXRA (0.44) ARFFAR4TP53MDM2CCNC
SCHEMBL3884516 0.80 FFAR4 (0.43) PDE1CARPDE4BPDE4DFFAR4
SCHEMBL3882273 0.80 SLC16A3 (0.48) FFAR1ARFFAR4TP53MDM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1477472-B1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF ASAHI KASEI PHARMA CORP (JP) 2009-01-14 EP claimed
US-6867320-B2 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2005-03-15 US claimed
EP-1477472-A1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF Asahi Kasei Pharma Corporation (JP) 2004-11-17 EP claimed
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2004-03-04 US claimed
EP-1477472-B1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF ASAHI KASEI PHARMA CORP (JP) 2009-01-14 EP disclosed
US-6867320-B2 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2005-03-15 US disclosed
EP-1477472-A1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF Asahi Kasei Pharma Corporation (JP) 2004-11-17 EP disclosed
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2004-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof PTGER1, CYSLTR1, PTGS1 FFAR1 13/4885PDE1C 3995/4885AR 630/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.